Snowball logo
logo
MITR_logo

Mithra Pharmaceuticals SA

MITRA β€’ BR
€0.216€0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20192020202120222023TTM
Revenue
Total revenue
96.529.0322.676740.16-
COGS
8.26399913.3326.1531.5634.16-
Gross Profit
88.26(4.3)(3.482)35.435.991-
Operating Expenses & Income
Operating Income
20.42(90.25)(92.69)(33.44)(69.32)-
Total Operating Expenses
67.8485.9589.268.8875.31-
R&D Expenses
57.0778.4685.2464.0463.17100.2
Selling General & Admin Expenses
14.7715.9312.5214.6822.0929.72
Earnings from Continuing Operations
Interest Expense
(3.366)(3.562)(12.12)(17.03)(22.9)(38.68)
Interest Income
0.558-2.1213.682--
Income Tax Expense
(6.449)(20.7)(9.462)46.0611.7155.49
Net Income
Net Income
(26.56)(92.09)(116.9)(59.62)(173.5)-
Supplemental
EBIT
78.26(71.33)(74.54)(33.44)(69.32)(91.9)
EBITDA
26.19(80.38)(82.26)(21.5)(57.11)-
In millions of EUR, except % and values per 1 share